Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
US Stock Market Move | Netskope (NTSK.US), a cybersecurity company, debuts on the US stock market with an opening price of $23.
The U.S. Supreme Court will hear oral arguments on the Trump tariff case on November 5th. The risk of a trillion dollar tax refund could trigger market volatility.
US Stock Market Move | AMD (AMD.US) fell over 2%, NVIDIA Corporation and Intel Corporation cooperating may pose a competitive challenge to AMD.
US Stock Market Move | Netskope (NTSK.US), a cybersecurity company, debuts on the US stock market with an opening price of $23.
The U.S. Supreme Court will hear oral arguments on the Trump tariff case on November 5th. The risk of a trillion dollar tax refund could trigger market volatility.
US Stock Market Move | AMD (AMD.US) fell over 2%, NVIDIA Corporation and Intel Corporation cooperating may pose a competitive challenge to AMD.
RECOMMEND
Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025
Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025
SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025
